Search Results - "FABRE, J. W."

Refine Results
  1. 1

    Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava by Fabre, J W, Grehan, A, Whitehorne, M, Sawyer, G J, Dong, X, Salehi, S, Eckley, L, Zhang, X, Seddon, M, Shah, A M, Davenport, M, Rela, M

    Published in Gene therapy (01-03-2008)
    “…Hydrodynamic gene delivery is an attractive option for non-viral liver gene therapy, but requires evaluation of efficacy, safety and clinically applicable…”
    Get full text
    Journal Article
  2. 2

    Technical requirements for effective regional hydrodynamic gene delivery to the left lateral lobe of the rat liver by Sawyer, G J, Zhang, X, Fabre, J W

    Published in Gene therapy (01-04-2010)
    “…Hydrodynamic gene delivery to the liver is an attractive approach for clinical liver gene therapy, but critical aspects of technique remain uncertain. There…”
    Get full text
    Journal Article
  3. 3

    The allogeneic response and tumor immunity by Fabre, John W

    Published in Nature medicine (01-06-2001)
    “…The strong allogeneic response to donor MHC molecules in transplantation and the weak response to tumor antigens represent two important and divergent but…”
    Get full text
    Journal Article
  4. 4

    Cardiovascular function following acute volume overload for hydrodynamic gene delivery to the liver by SAWYER, G. J, DONG, X, WHITEHORNE, M, GREHAN, A, SEDDON, M, SHAH, A. M, ZHANE, X, FABRE, J. W

    Published in Gene therapy (01-08-2007)
    “…Hydrodynamic gene delivery to the liver is a valuable experimental tool and an attractive option for nonviral gene therapy of liver disease. However, little…”
    Get full text
    Journal Article
  5. 5

    Integrin-mediated transfection with peptides containing arginine-glycine-aspartic acid domains by HART, S. L, COLLINS, L, GUSTAFSSON, K, FABRE, J. W

    Published in Gene therapy (01-11-1997)
    “…Two synthetic peptides comprising an RGD moiety for integrin binding and a polylysine moiety for DNA binding were tested for transfection efficiency under a…”
    Get full text
    Journal Article
  6. 6

    A remarkable permeability of canalicular tight junctions might facilitate retrograde, non-viral gene delivery to the liver via the bile duct by Hu, J, Zhang, X, Dong, X, Collins, L, Sawyer, G J, Fabre, J W

    Published in Gut (01-10-2005)
    “…Aims: To establish the extent of retrograde bile duct infusion at an ultrastructural level, as a preliminary step before evaluating the efficacy of gene…”
    Get full text
    Journal Article
  7. 7

    Rejection of skin allografts by indirect allorecognition of Donor class I major histocompatibility complex peptides by FANGMANN, J, DALCHAU, R, FABRE, J. W

    Published in The Journal of experimental medicine (01-06-1992)
    “…LEW (RT1l) rats were immunized with peptides corresponding to the alpha helical region of the alpha 1 domain (peptide 1), the beta sheet of the alpha 2 domain…”
    Get full text
    Journal Article
  8. 8

    Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection by Li, J.-M, Collins, L, Zhang, X, Gustafsson, K, Fabre, J.W

    Published in Transplantation (01-02-2001)
    “…Chronic rejection is now the major cause of allograft failure. A prominent characteristic of the histopathology is extensive intimal proliferation of vascular…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    The detailed distribution of MHC Class II antigens in normal human organs by Daar, A S, Fuggle, S V, Fabre, J W, Ting, A, Morris, P J

    Published in Transplantation (01-09-1984)
    “…In a previous article we described the detailed tissue distribution of MHC class I antigens. In this study, we have used a monoclonal antibody, NFK1, to study…”
    Get more information
    Journal Article
  10. 10

    Massive induction of donor-type class I and class II major histocompatibility complex antigens in rejecting cardiac allografts in the rat by MILTON, A. D, FABRE, J. W

    “…DA (RT1a) hearts were transplanted into PVG (RT1c) or DA recipients, excised on days 1, 3, 5, or 7 after grafting, and examined by immunohistological…”
    Get full text
    Journal Article
  11. 11

    The detailed distribution of HLA-A, B, C antigens in normal human organs by Daar, A S, Fuggle, S V, Fabre, J W, Ting, A, Morris, P J

    Published in Transplantation (01-09-1984)
    “…We have used a monoclonal antibody, PA2.6, directed against the heavy chain of HLA-ABC antigens to study the detailed tissue distribution of MHC class I…”
    Get more information
    Journal Article
  12. 12

    Suppression of human anti-porcine T-cell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain by SHENG YUN, GUSTAFSSON, K, FABRE, J. W

    Published in Transplantation (15-07-1998)
    “…The class II transactivator (CIITA) is a bi- or multifunctional domain protein that acts as a transcriptional activator and plays a critical role in the…”
    Get full text
    Journal Article
  13. 13

    Characterization of the tissue macrophage and the interstitial dendritic cell as distinct leukocytes normally resident in the connective tissue of rat heart by SPENCER, S. C, FABRE, J. W

    Published in The Journal of experimental medicine (01-06-1990)
    “…Immunohistological studies with a mouse anti-rat macrophage mAb (BMAC-5) demonstrated the presence of numerous positive cells in the interstitial connective…”
    Get full text
    Journal Article
  14. 14

    Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts by Benham, A M, Sawyer, G J, Fabre, J W

    Published in Transplantation (15-04-1995)
    “…This report demonstrates for the first time that indirect T cell allorecognition of donor antigens can contribute to the effector mechanism of rejection of…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Comparison of adenovirus gene transfer to vascular endothelial cells in cell culture, organ culture, and in vivo by MERRICK, A. F, SHEWRING, L. D, SAWYER, G. J, GUSTAFSSON, K. T, FABRE, J. W

    Published in Transplantation (27-10-1996)
    “…A replication-defective adenovirus 5 vector carrying the beta-galactosidase reporter gene was tested for its efficiency for gene delivery to vascular…”
    Get full text
    Journal Article
  17. 17

    Chemical composition and tissue distribution of the human CDw44 glycoprotein by FLANAGAN, B. F, DALCHAU, R, ALLEN, A. K, DAAR, A. S, FABRE, J. W

    Published in Immunology (01-06-1989)
    “…The CDw44 glycoprotein was purified from 2.3 x 10(11) CD3+ CD4+ CD8- T-chronic lymphocytic leukaemia (CLL) cells using F10-44-2 monoclonal antibody affinity…”
    Get full text
    Journal Article
  18. 18

    A three-cell cluster hypothesis for noncognate T-B collaboration via direct T cell recognition of allogeneic dendritic cells by KELLY, C. M, BENHAM, A. M, SAWYER, G. J, DALCHAU, R, FABRE, J. W

    Published in Transplantation (15-04-1996)
    “…In this article, we propose that T cell help for B cells can occur via an unusual three-cell cluster, with recipient CD4+ T helper cells interacting via direct…”
    Get full text
    Journal Article
  19. 19

    Specific suppression of interleukin 2 biosynthesis by synthetic antisense oligodeoxynucleotides does not influence allograft rejection by SHENG YUN, SAWYER, G. J, XIAOHONG ZHANG, GUSTAFSSON, K, FABRE, J. W

    Published in Transplantation (27-06-2000)
    “…Interleukin (IL)-2 supplementation can reverse both blood transfusion-induced tolerance to kidney allografts and spontaneous tolerance to liver allografts in…”
    Get full text
    Journal Article
  20. 20

    T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection by Fangmann, J, Dalchau, R, Sawyer, G J, Priestley, C A, Fabre, J W

    Published in European journal of immunology (01-06-1992)
    “…LEW (RTI1) recipients of DA (RTIav1) skin and kidney allografts were tested for the capacity of their T lymphocytes to proliferate to three 22-24-amino acid…”
    Get more information
    Journal Article